Treatment for Helicobacter pylori appears to reduce the incidence of gastric cancer: eradication effect or screening effect?

Affiliations

¹ Health Development Center, Tokyo Pharmaceutical Industry Health Insurance Society, Tokyo, Japan.
² Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Comment

Yutaka Yamaji et al. Gut. 2020 Mar.

. 2020 Mar;69(3):605-606.

doi: 10.1136/gutjnl-2018-318206. Epub 2019 Feb 12.

¹ Health Development Center, Tokyo Pharmaceutical Industry Health Insurance Society, Tokyo, Japan.
² Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

No abstract available

Keywords: cancer prevention; gastric carcinoma; helicobacter pylori - treatment.

Conflict of interest statement

Competing interests: None declared.

Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N. Doorakkers E, et al. Gut. 2018 Dec;67(12):2092-2096. doi: 10.1136/gutjnl-2017-315363. Epub 2018 Jan 30. Gut. 2018. PMID: 29382776